KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
Open Access
- 2 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 28 (4), 1284-1300
- https://doi.org/10.1038/s41418-020-00651-5
Abstract
In addition to the role of programmed cell death ligand 1 (PD-L1) in facilitating tumour cells escape from immune surveillance, it is considered as a crucial effector in transducing intrinsic signals to promote tumour development. Our previous study has pointed out that PD-L1 promotes non-small cell lung cancer (NSCLC) cell proliferation, but the mechanism remains elusive. Here we first demonstrated that PD-L1 expression levels were positively correlated with p-MerTK levels in patient samples and NSCLC cell lines. In addition, PD-L1 knockdown led to the reduced phosphorylation level of MerTK in vitro. We next showed that PD-L1 regulated NSCLC cell proliferation via Gas6/MerTK signaling pathway in vitro and in vivo. To investigate the underlying mechanism, we unexpectedly found that PD-L1 translocated into the nucleus of cancer cells which was facilitated through the binding of Karyopherin β1 (KPNB1). Nuclear PD-L1 (nPD-L1), coupled with transcription factor Sp1, regulated the synthesis of Gas6 mRNA and promoted Gas6 secretion to activate MerTK signaling pathway. Taken together, our results shed light on the novel role of nPD-L1 in NSCLC cell proliferation and reveal a new molecular mechanism underlying nPD-L1-mediated Gas6/MerTK signaling activation. All above findings provide the possible combinational implications for PD-L1 targeted immunotherapy in the clinic.Keywords
This publication has 55 references indexed in Scilit:
- Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non–Small-Cell Lung CancerJAMA Oncology, 2016
- Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and functionBlood, 2015
- Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function CapacityOnline Journal of Public Health Informatics, 2014
- Regulation of Nucleocytoplasmic Transport by ADP-Ribosylation: The Emerging Role of Karyopherin-β1 Mono-ADP-Ribosylation by ARTD15Current Topics in Microbiology and Immunology, 2014
- TAM receptors, Gas6, and protein S: roles in inflammation and hemostasisBlood, 2014
- Galectin‐3 is a new MerTK‐specific eat‐me signalJournal of Cellular Physiology, 2011
- Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic moleculeBreast Cancer Research, 2010
- Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene ExpressionOnline Journal of Public Health Informatics, 2009
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cellsBlood, 2008
- POZ Domain Transcription Factor, FBI-1, Represses Transcription of ADH5/FDH by Interacting with the Zinc Finger and Interfering with DNA Binding Activity of Sp1Online Journal of Public Health Informatics, 2002